Oral supplementation with probiotics, potassium citrate, and magnesium in reducing crystalluria in stone formers: A phase II study.

Autor:	Vittori M; Department of Urology, San Carlo di Nancy Hospital, GVM Care and Research, Rome, Italy., Bove P; Department of Urology, San Carlo di Nancy Hospital, GVM Care and Research, Rome, Italy.; Department of Urology, Tor Vergata University of Rome, Rome, Italy., Signoretti M; Department of Urology, San Carlo di Nancy Hospital, GVM Care and Research, Rome, Italy., Cipriani C; Department of Urology, San Carlo di Nancy Hospital, GVM Care and Research, Rome, Italy., Gasparoli C; Department of Urology, San Carlo di Nancy Hospital, GVM Care and Research, Rome, Italy., Antonucci M; Department of Urology, San Carlo di Nancy Hospital, GVM Care and Research, Rome, Italy., Carilli M; Department of Urology, San Carlo di Nancy Hospital, GVM Care and Research, Rome, Italy., Maiorino F; Department of Urology, San Carlo di Nancy Hospital, GVM Care and Research, Rome, Italy., Iacovelli V; Department of Urology, San Carlo di Nancy Hospital, GVM Care and Research, Rome, Italy., Petta F; Department of Urology, San Carlo di Nancy Hospital, GVM Care and Research, Rome, Italy., Travaglia S; Department of Urology, San Carlo di Nancy Hospital, GVM Care and Research, Rome, Italy., Panei M; Department of Urology, San Carlo di Nancy Hospital, GVM Care and Research, Rome, Italy., Russo P; Department of Urology, Catholic University of the Sacred Heart, Agostino Gemelli Hospital, Rome, Italy., Bertolo R; Department of Urology, San Carlo di Nancy Hospital, GVM Care and Research, Rome, Italy.; Department of Urology, University of Verona, Verona, Italy.
Jazyk:	angličtina
Zdroj:	Urologia [Urologia] 2024 Nov; Vol. 91 (4), pp. 681-686. Date of Electronic Publication: 2024 Aug 29.
DOI:	10.1177/03915603241272146
Abstrakt:	Introduction: Crystalluria is an important indicator of renal stone recurrence. Mechanisms underlying urinary stone formation are still not fully understood and raising interests has been giving to intestinal commensal bacteria for their contribute in maintaining urinary solutes equilibrium. The aim of our phase II study was to examine the administration of potassium citrate, magnesium and probiotics in order to reduce crystalluria. Materials and Methods: Since May 2021, we enrolled 23 patients candidates for ureterorenolithotripsy for calcium oxalate kidney stones with crystalluria and a normal metabolic profile. The analysis was validated by the Institution's Ethical Committee (no. approval STS CE Lazio 1/N-823). At discharge, patients were provided with daily food supplementation for 20 days of 1 billion Lactobacillus paracasei LPC09, 1 billion Lactobacillus plantarum LP01, 1 billion Bifidobacterium breve BR03, potassium (520 mg), citrate (1400 mg), and magnesium (80 mg). Crystalluria was re-assessed at 1, 3, 6, and 12-months follow-up by polarized light microscopy. Results: After one month from the oral supplementation, no patient reported crystalluria; at 3 months, among the 20 participants available for re-evaluation, still no patient reported crystalluria. Instead, crystalluria was reported in three patients (15%) at 6 months, and in five patients (25%) at 12 months follow-up. Conclusions: The oral supplementation with Lactobacillus spp. and Bifidobacterium spp. was found able to reduce the prevalence of crystalluria in a cohort of patients with diagnosis of calcium oxalate kidney stones with crystalluria candidate to ureterorenolithotripsy. Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu